Vestergaard Peter
The Osteoporosis Clinic, Aarhus Amtssygehus, Aarhus University Hospital, Tage Hansens Gade 2, DK-8000 Aarhus C, Denmark.
Eur J Endocrinol. 2002 Feb;146(2):153-61. doi: 10.1530/eje.0.1460153.
Smoking has been associated with Graves' disease, but it remains unclear if the association is present in other thyroid disorders.
Graves' disease, Graves' ophthalmopathy, toxic nodular goitre, non-toxic goitre, post-partum thyroid disease, Hashimoto's thyroiditis, or hypothyroidism.
A search of MEDLINE identified 25 studies on the association between smoking and thyroid diseases.
In Graves' disease eight studies were available showing an odds ratio (OR) of 3.30 (95% confidence interval (CI): 2.09-5.22) in current smokers compared with never smokers. In ex-smokers there was no significant excess risk of Graves' disease (OR=1.41, 95% CI: 0.77-2.58). The OR associated with ever smoking in Graves' ophthalmopathy (4.40, 95% CI: 2.88-6.73, six studies) was significantly higher than in Graves' disease (1.90, 95% CI: 1.42-2.55, two-sided P-value <0.01). Ever smoking was not associated with toxic nodular goitre (OR=1.27, 95% CI: 0.69-2.33, three studies), while there was an increased risk of non-toxic goitre in smokers if men were excluded (OR=1.29, 95% CI: 1.01-1.65, eight studies). The risk associated with smoking was significantly lower in men than in women for both Graves' disease and non-toxic goitre. Hashimoto's thyroiditis and post-partum thyroid dysfunction were also associated with smoking while the association with hypothyroidism did not reach statistical significance.
Cessation of smoking seems associated with a lower risk of Graves' disease than current smoking. Smoking increases the risk of Graves' ophthalmopathy beyond the risk associated with Graves' disease alone. Smoking cessation may lead to a decrease in morbidity from Graves' disease, especially in women.
吸烟与格雷夫斯病有关,但吸烟与其他甲状腺疾病之间是否存在关联尚不清楚。
格雷夫斯病、格雷夫斯眼病、毒性结节性甲状腺肿、非毒性甲状腺肿、产后甲状腺疾病、桥本甲状腺炎或甲状腺功能减退症。
检索MEDLINE数据库,共识别出25项关于吸烟与甲状腺疾病关联的研究。
在格雷夫斯病方面,有8项研究表明,与从不吸烟者相比,当前吸烟者的优势比(OR)为3.30(95%置信区间(CI):2.09 - 5.22)。既往吸烟者患格雷夫斯病的额外风险无显著增加(OR = 1.41,95% CI:0.77 - 2.58)。在格雷夫斯眼病中,与曾经吸烟相关的OR(4.40,95% CI:2.88 - 6.73,6项研究)显著高于格雷夫斯病(1.90,95% CI:1.42 - 2.55,双侧P值<0.01)。曾经吸烟与毒性结节性甲状腺肿无关(OR = 1.27,95% CI:0.69 - 2.33,3项研究),而排除男性后,吸烟者患非毒性甲状腺肿的风险增加(OR = 1.29,95% CI:1.01 - 1.65,8项研究)。在格雷夫斯病和非毒性甲状腺肿中,男性吸烟相关风险均显著低于女性。桥本甲状腺炎和产后甲状腺功能障碍也与吸烟有关,而吸烟与甲状腺功能减退症的关联未达到统计学显著性。
与当前吸烟相比,戒烟似乎与较低的格雷夫斯病风险相关。吸烟增加了格雷夫斯眼病的风险,且超出了仅与格雷夫斯病相关的风险。戒烟可能会降低格雷夫斯病的发病率,尤其是在女性中。